3 recruiting, 2 terminated. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 3, Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow IBD: new trials by email Literature Review of IBD trials Research Report on IBD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease Vancomycin /Amphotericin B (Fungizone®) /Gentamicine 80 mg, Inulin/Inulin C13 - IBD, Crohn Disease | Phase 2 | Recruiting | Assistance Publique - Hôpitaux de Paris | 45 | 2026-01-02 | 2026-03-12 |
| Fluorescence Imaging of IBD and RA Using Adalimumab-800CW Adalimumab-800CW, Fluorescence Imaging - IBD, Rheumatoid Arthritis | Phase 2 | Recruiting | University Medical Center Groningen | 36 | 2024-08-06 | 2025-08-19 |
| Vancomycin in Primary Sclerosing Cholangitis in Italy Oral Vancomycin, Placebo - Primary Sclerosing Cholangitis, Liver and Intrahepatic Bile Duct Disorder | Phase 2 | Recruiting | University of Milano Bicocca | 84 | 2023-06-15 | 2025-07-25 |
| An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease Brazikumab low dose, Brazikumab high dose, Humira® - Crohn's Disease, IBD | Phase 2 / Phase 3 | Terminated | AstraZeneca | 89 | 2018-12-07 | 2026-06-23 |
| Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis Brazikumab, Placebo - Ulcerative Colitis, IBD | Phase 2 | Terminated | AstraZeneca | 242 | 2018-08-07 | 2026-06-23 |
Inflammatory Bowel Diseases (3) · Colitis, Ulcerative (2) · Crohn Disease (2) · Arthritis, Rheumatoid (1) · Cholangitis, Sclerosing (1) · Digestive System Diseases (1)
Gastroenteritis (5) · Gastrointestinal Diseases (5) · Intestinal Diseases (5) · Digestive System Diseases (4) · Colitis (2) · Colonic Diseases (2) · Inflammatory Bowel Diseases (2) · Arthritis (1) · Autoimmune Diseases (1) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Cholangitis (1) · Connective Tissue Diseases (1) · Immune System Diseases (1) · Joint Diseases (1)
Adalimumab (2) · Vancomycin (2) · Amphotericin B (1) · Inulin (1) · Optical Imaging (1)
AstraZeneca (2) · Assistance Publique - Hôpitaux de Paris (1) · University Medical Center Groningen (1) · University of Milano Bicocca (1)
Italy (3) · Canada (2) · Czechia (2) · Germany (2) · Hungary (2) · India (2) · Israel (2) · Poland (2) · Russia (2) · Slovakia (2) · South Africa (2) · South Korea (2) · Spain (2) · Taiwan (2) · Ukraine (2)
Kathy Bohannon (2) · Wouter B. Nagengast, MD, PhD, PharmD (1)
2018 (2)